current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: IDP00005 internalin, putative BA_0552 [Bacillus anthracis str. Ames], from CSGID

Results of FFAS03 search in PfamA30U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070
# Score Template Links and tools%idFirst MLVAATLSLPFAVYATPILAATAATENMAVQSPKKHVFDAVIKAYKDNSDEESYATVYIKDPKLTIENGKRIITATLKDSDFFDYLKVEDSKEPGVFHDVKVLSEDKRKHGTKVIQFEVGELGKRYNMQMHILIPTLGYDKEFKIQFEVNMRTFVESDIEEDEEEQIEDTQNIIRDKRLQQAINKNVLNRKDVNEPIFEEDLKEIKELNIYAGQGIESLKGLEYMENLERITIQGSDVRNIAPISQLKRLKVVDLSFNKIENVEPLVNLEKLDILELQNNRIADVTPLSQLKKVRTINLSGNKISDIKPLYNVSSLRKLYVSNNKITDFTGIEQLNKLGTLGVGSNGLVNIEPISQMSGIVELNLEKNDIKDITSLSKLTGLQSLNLEENYVSDVSSLSNLINLYELKLATNEIRDIRPIQELGKRIKIDAQRQKVFLDEAYMNEEVKIPVYDVNGTALQNIEWKSEGGSITNGVIKWNSLGEKMYEFKMDAGESKIRFQGRVIQNIVEKREESSNVIQDMKLRQYMNKHNFERKNVNTPITKEDLLTVKALKITDGKKEGITDFSGLEFMTNVEELTLQNVNMKNAEFISSLRNLKSVDLSYNQIEDIKPLHSLEDLEKLNVSDNGIKNVPELFKMQKLKTLDLSNNKLDNAALDGIHQLENLDALLVNNNEINNLDEISKVSKLNKLEMMSNKVRDISPLASLKNLQWLNLSDNKIQDISTLSSMLDLLSLKLAGNEIRDVRPVIQLAQWITVDIKNQKIVLEDGQMNQEIQIPIYDLEGEIFEDIELKSTDGIVTDRGTVVWKTPGAKIYSFSLNGNYHGLSLLFSGTVTQNIVAKEEPKEPVEEVEGSKEEPIKEAEGSKEEPKEPAKEVEGSKEEPKEPAKEVEGSKEEVKEPAKEVEGPKEEVKEPTKEVEGPKEEVKEPTKEVEGPKEEVKEPMKEVEGSKEEVKGPTKEAEGSKEEVKEPTTEVEGSKEVKEPGKEVEGSKDAINQSAVAQETNVNNQVGKEKVVENQNMKENKPAVTKQEESKKSLGATGGQENTSTLLSGLALVLSALSMFVFRKRLFKKLast
1 -27.700PF14580.4; H3BFR2_LATCH/1-175; Leucine-rich repeat  ali follow..  22  2................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VKLSAELIEQAAQYTNPVRDRELDLRGYKIPVIENLGALDQFDTIDFSDNEIRKLDGFPLLKRLKTLLMNNNRICRIGEGLEQALPNLRELILTSNSIQELDPLASIKSLTFLSILRNPVTNKKHIHKVPQIRVLD...................................................................................................................................................................................................................................................................................................................................................................... 146
2 -18.500PF15677.3; H2NCC0_PONAB/1-152; Cell cycle exit and neuronal differentiation protein 1  ali follow..  11  2..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ESRGKSASSPKPDTKVPQATTEAKVPPAADGKAPLTKSSKKEAPAEKQQPPAAPTTAPAKKTPAKAD-PALLNNHSNLKPAPTAPTVPSSPDATPEPKGPGDGAEEDEAASGGPGGRGPWSCENFNPLLVAGGVAVAAIALILGVAFL---------RKK.... 152
3 -16.800PF15762.3; G1P4D6_MYOLU/1-188; Domain of unknown function (DUF4691 topsan)  ali follow..  19  48......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LVSAHEVCGTQGEDKRPTGPVSEPELQEERPKLEEERLKPEVEALEERGPRPMASVVRSSHGPKRKPVNLPGPSHQAHPRAEAELPQGLPLQREDLEGSQSEPSPSTKQHKKAKKRKSLAAPVLPAVASTASAPSE................................ 183
4 -16.100PF16602.3; I3IZD7_ORENI/408-535; Linker region of USP19 deubiquitinase  ali follow..  2........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HSQRWGGLEAQATQGAVGGAKVAVPSSPACMEKSQPGSSQHNLPAKEEPPRVGEEKPKTPKASTR-----VEDGGLDSVAPRTVSEHVAITKPEPTVTMPKPTCMVQPMTHAPPASSER---HEEEEEKKVCLPG............................... 128
5 -15.900PF16031.3; A6TAJ3_KLEP7/36-167; TonB N-terminal region  ali follow..  15  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HQVIEQPSPTQPIEITMVAPADLEPPPAAQPVVEPVVEPEPEPEPEVVPEPPKEAPVVIHKPEPKPKPKPKPKPKPEKKVEQPKREVKPAAEPRPASPFENNNTAPARTAPSTSTAAAKPTVTAPSGPRAIS................................. 132
6 -15.700PF05104.10; G3NLP1_GASAC/33-177; Ribosome receptor lysine/proline rich region  ali follow..  10  1...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MKETSYEEALAKQRSELGKIHSARSDKKKKDKVSEKKGRGKKKEDKPNGKIPEPDETQEDVEADVV-VEPAAAPVVAAAPEPERVPDLDVKPNAATAAPEPTTAPEPSPAVIERSPAPSPKEKKKKKVAKA................................ 130
7 -14.800PF05558.10; I1NLL8_ORYGL/3-193; DREPP plasma membrane polypeptide  ali follow..  12  9.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TGLNKLFDKDGKKAAAAEFLKSFNKEEIGKEIDDKKTELEPKVVEVVESSPPEIKALLKDKKTASKIKKNGPAVTKFLEELAKIDFPGAKPVSDAVAKSGTTPLSPAIAFILEKVAPFVPKEEPKPEPEAEAAAETTSREV................................ 149
8 -14.000PF15356.4; G5C3D2_HETGA/23-136; Psoriasis susceptibility locus 2  ali follow..  3....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DHSSPPSTEAREEESPPRLPLGPPIPGEPWPGAPPLFEDPPPPGPSHPWGDLPDSGVWPPEAPSTDPPQPPLPDDPWPAGPQPPANPWPPAPEVDHKPHNEPDLDPPREEYR.......................................... 114
9 -14.000PF15231.4; G3RM09_GORGO/1-140; Variable charge X/Y family  ali follow..  14  1...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MSPKPSASGPPAKAEETGKRKSSSQLSPSGPKKKTTKVAKKGKAARGGRGRKKGAATKMAAVTAPEAESGPAAPGPSDQPSQELPQHELPPEEPVSEGSQHDPLSQETELEEPLSQGWPST.......................... 121
10 -13.900PF15442.4; G3IHG1_CRIGR/473-619; Domain of unknown function (DUF4629 topsan)  ali follow..  14  1.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PSDQVRKGNQNASELLDGAPQVKNQCQDVVEG-ARASEGAIDNMAKHLDGTAQKSAHSRPRISRAQGQDKNKRTRENKTKKKGELKPSCPRVKAEEKPTIPKTKRTRNP-----SQDSFKKPRTHLGMMLESVQVF---HPLGKK 146
11 -13.800PF15140.4; ERIC5_MOUSE/95-251; Domain of unknown function (DUF4573 topsan)  ali follow..  17........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GGECEQPQPGGKDDMLGTEEVKKDVEARTEVPSLKGDAEIKPLRLSSERDSPGAPQAGTMKFLQTAENILPLETTQELPPKEATGKGAQPQILEAIPKENSSPEIEGIQSAESSGQQQLVEAPGEAEQPQALETVLKENET......................... 157
12 -13.800PF16617.3; W5MI93_LEPOC/795-917; Intersectin and clathrin adaptor AP2 binding region  ali follow..  11  1...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KIPESDVPASLKPGAGSA------------PKVAARVTPTSAVSAGSQPPPAETPAAPPTTTAAGSNWADFSSTWPSNNSEKTEGDGWDAWPTQPSLTVPSTGQLRQRSAFTPATITGSSPS......................... 110
13 -13.500PF06614.9; F7FEE8_MACMU/67-238; Neuromodulin  ali follow..  12  11........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GVEKKGEGTTATEAAPATGSKPDEPGKAGETPSEEKKGEGDAATEQAAPQAPASSEEKAGSAETESATKASTDNSPSSKAEDAPAKEEPKQADVPAAVTAAAATTPAAEDAAAKATAQPPTETGESSQAEENIEAVDET........................... 149
14 -13.300PF13855.4; C3Y9A4_BRAFL/119-179; Leucine rich repeat  ali follow..  25  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PRLYDLSLDSNRLTHVKQFTGLENLLSLTLSNNRIEKIEAGSFAYLDRLQHLYLENNLL............................................................................................................................................................................................................................................................................................................................................................................................................ 61
15 -13.200PF05177.10; G3TIA9_LOXAF/230-330; RCSD region  ali follow..  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RSMGSEEKPPLRRTSSMIETREEKGRAAEEAKHGEKAAEHSADKEPQSPAQGEAAEPETSSPKAENGPGTPTEETMAGEEVETEKSAEVKEERAENE.................................... 97
16 -13.100PF14755.4; D7P484_EAV/361-513; Intracellular membrane remodeller  ali follow..  7...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VSASVLDHILEAATFGNVRVVATEEQQRPVPAPRARHSVSPPGDVKDTATVPPVPKPRTKLAKPSPVQAPTPAPRTQPQDAVHSGLPKPEPPTGTAAAPASAPRWRVAKTVYSSAERIRTELIHRAQSIGDSLV......................... 140
17 -12.900PF15755.3; G3TX68_LOXAF/1-223; Domain of unknown function (DUF4689 topsan)  ali follow..  92........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SEDWYGSAVPLLMDGAPEALNPGGTLEARATAPSAPSAPHSPPSSLVFQAPPQVPARSTFCVPQPWEERSHNTGMVSWAEPEPRPGDSVYLGSPRAQRHRPGSPEPGWGLQPLVTLEQISAFWRREGRTS---VG............................... 223
18 -12.300PF00997.16; E2QXF8_CANLF/23-184; Kappa casein  ali follow..  1..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EVQNQEQPTCRENDERLFNQKTVKYIPIHYVLNSFSHYEPNYYPHRPAEPINHQYVPYPFYAKPAVAVRTHAQIPQWQVLPNAYPPTMMHRPQLHPSFIAIPPKKIQDKTSIPTINTIATAEAT................................ 124
19 -12.300PF05887.9; PAR1_TRYBB/1-143; Procyclic acidic repetitive protein (PARP)  ali follow..  15  3........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PRSLYLLAVLLFSANLFAGVGFAAAAEGPEDKGLTKGGKGKGEKGTKVGADDTNGTDPDPEPEPEPEPEPEPEP-EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPGAATLKSVALP-FAIAAAALVAAF....................... 143
20 -12.300PF12406.6; Q8WPH8_THEAN/26-124; Surface protein  ali follow..  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DRQLNPIDFDPNDDQHPLDPDQLIDQIEPSEQPAQQEPIEPQQPTQPSTEPEELQPETVTVEVPEPVTSEEPKESDQTEEQKHEEPEASPAPEPVDE-PA................................. 99
21 -12.300PF16620.3; L5L3U3_PTEAL/250-410; Unstructured linker between I-set domains 2 and 3 on MYLCK  ali follow..  5........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NANRSFVRGTKAANSDIRKEVTNGIAQEPKMDSLETIAESKNCSSTQRGGSPTWATSTQPQPLRESKLDLFEDSSRKALRTPVLQKTSSTITLQATKVQPEPRAPVSGPFSPGEKREKPAAPPPATLPTRQSGLRSQEVVS......................... 145
22 -12.200PF12526.6; Q8JJN7_HEV/686-799; Protein of unknown function (DUF3729 topsan)  ali follow..  4.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ESTNPFCGESTLYTRTWSVSGFSSCFSPLEPPASGSLPPAEIDPPVTVDAPSPSILALPRPSVFEQTTPPLDPAGDAAASAPPGAPGVPPAPARPVTHPSGPRRRLLHTYP.................................. 114
23 -12.100PF14962.4; H0WJV0_OTOGA/1-192; Mitochondria Localisation Sequence  ali follow..  11  65......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KTVTSDQAKHTEHITNMKEKTKAELHPLQGEKEHIAEAEKASPEAPEVSVVEAEVVAAEEIPDATVAALTEASACPGGVEAAPETAASGAETAPEVPEAVVGDTTEEVSAGTTPEVTDPTLGEAVAID........................................ 192
24 -12.100PF15485.4; G3UKN2_LOXAF/6-263; Domain of unknown function (DUF4643 topsan)  ali follow..  120...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PRVASKPRLSGWTRLKKQLMVEEVEPPAQSPAQSPGATRQEKVAPALPAPRPPTFRASKMWDAVGDQSRTAGPGEGTRTLTSMSRLPFLCRPRFNARKLQEAAVRPPPKALPALRLSPQPENNRTAAG............................... 255
25 -12.000PF11029.6; B7PCU4_IXOSC/14-160; DAZ associated protein 2 (DAZAP2)  ali follow..  10  4........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PYTAPYPAPYPAGGFPASHSLPSGGGYWPQPQTTQPMDHAAKMYPAPGQGYGQAPPAPPQYAGASYPQQPVVPQANQTTVYHVPDAFDAGARFSANTPASIPPPPPGVMPNAAQLAAMQGNQVVLGQKKSTFLSGTGGAGYTF....................... 146
26 -11.800PF05808.9; F6ZBL8_HORSE/19-167; Podoplanin  ali follow..  12  20..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AEGASTVAEDDFKTPGVAMHGDPSDSEEPYESAGLTALVPTNTESITDIHTEVLPTPGNTVHAQEETQITTPNVVASHSMEKVGEETQTTVEDNGLVTVTLVRGVLLAIGFISIIVVMKR.... 144
27 -11.800PF15724.3; L5JX75_PTEAL/24-275; TMEM119 family  ali follow..  12  125....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AFSEVPDKDPDGRPEEALDSSQQLQADILAATQNLKSPARVASSSGNGARVTEGKSEEEEKGSQEADREAEGRGVSVERAEVAEDPCLAVVEGAVGAGEGPGEPEAAPSLSQEAEGPAGPACG............................... 252
28 -11.600PF00985.15; MSA2_PLAF7/102-272; Merozoite Surface Antigen 2 (MSA-2) family  ali follow..  14........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TSTSSENPNHKNAETNPKGKGEVQEPNQANKETQNNSNVQQDSQTKSNVPPTQDADTKSPTAQPEQAENSAPTAEQTESPELQSAPENKGTGQHGHMHGSRNNHPQNTSDSQKECTDGNKENCGAATSLLNNSSNIASINKFVVLISATLVLSFAIFI........ 171
29 -11.600PF04538.10; H0W9V3_CAVPO/1-170; Brain expressed X-linked like family  ali follow..  14  27........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EGKIEKEEKTDHEGKPAFEGKLEGEGEPNVERQGKNEGKPEMQSKLGDEGSPQGEGNAESQARPENKQLPAEKHLAEDYVPRKAKRKTDRGTEDSPKDSQENLQDTHLSREEMMREFADMSRGQEELRKKQRINNFYWMQRELL...................... 170
30 -11.500PF05466.10; F6R3X8_HORSE/2-233; Brain acid soluble protein 1 (BASP1 protein)  ali follow..  13  21...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KDKKAEGAGTEEEGTPKENETQAAAETTEVKEGKEEKPEKDAQDAANKPEDKEGEKDADAAKEDAPKAEPEQTEGAAEGKPEPPKDAKDGEQEQAAASGPAAGGDAPKASEAEAPAEPAPTKVDDKSKEGGEPTKTEAPAAPAAQETKS.......................... 169
31 -11.500PF12301.6; G3N6P2_GASAC/29-223; CD99 antigen like protein 2  ali follow..  40.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................APVTTPVKPKPKPAAADDFDLSDALDSNNDIGIKDKNKGQGDKIKTDNDPTFQSRGFSDNDLFDVSKDETYHPDKGKGGRPSGSKDQLDQYDENSDTTAEVGTIAGIASAV-AMALVGAVSSYISYQKKKL.. 169
32 -11.500PF15512.4; F6U7T6_HORSE/381-555; Chromatin assembly factor complex 1 subunit p60, C-terminal  ali follow..  2.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................IPLKEKPVLSVRTPDTAKKTKSQTPQGSLPGPRLAEGTPTSRTQDSSPGTPPPQVKQSPASTAAKDTPGTAPGARSSLPGSSEEKTLQPSSQNVKAHPSRRVTLNTLQAWSKTTPRRINLIPLKTDTPLNSVPNSIISTSAT......................... 144
33 -11.500PF05058.10; ACTA_LISMO/7-639; ActA Protein  ali follow..  11  469......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KTPFKNPSQPLNVFNKKTTTKTVTKKPTPVKTAPKLAELPATKPQETVLRENKTPFIEKQAETNKQSINMPSLPVIQKEATESD--KEEMKPQTEEKMVEESESANNANGKNRSAGIEEGKLIAKSAEDEKAKEEPG--NHTTLILA--MLAIGVFSLGAFIKQLRKN 632
34 -11.500PF15748.3; G3GX24_CRIGR/7-250; Centriole, cilia and spindle-associated  ali follow..  13  82........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RGAEVGDAEEQDTVLPAPPKKDIEEKPELQTGAKETDRVPSGPEPRQHPSALFARGSKKATRSPQRSTSKIKENKHPFALYGWGEKQMDTGSQKTHNVCASASVHEIHESALRAKNRRQVEKRKLAAQRQRAHSVDVEKN.......................... 221
35 -11.400PF07382.9; A0A0E9ASG6_CHLTH/1-221; Histone H1-like nucleoprotein HC2  ali follow..  10  73....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KAVAKKTVARKTVAKKTVAARKPVAKKATAKKAPVRKVAAKKTVARKTVAKKTVAARKPVAKKATAKKAPVRKAVAKKTVAKRVASTKKSSVAVKAGVCMKKHKHTAACGRVAASGVKVCASAAKRKMN......................... 201
36 -11.300PF06390.10; GNAS3_MOUSE/1-257; Neuroendocrine-specific golgi protein P55 (NESP55)  ali follow..  110......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DYETETDSETEPESDIESETEIETEPETEPETAPTTEPETEPEDERGPRGATFNQSLTQRLHALKLQSADASPRRAQPTTQEPESASEGEEPQRGPLDQDPRDPEEEPEERKEENRQPRRCKTRRPARRRDQSPESPPRKG........................... 250
37 -11.100PF03363.11; EBNA5_EBVB9/331-504; Herpesvirus leader protein  ali follow..  27........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LLRRHRSPSPTRGGQEPRRVRRRVLVQQEEEVVSGSPSGPRGDRSEGPGPTRPGPPGIGPEGPLGQLLRRHRSPSPTRGGQEPRRVRRRVLVQQEEEVVSGSPSGPLRPRPRPPARSLREWLLRIRDHFEPPTVTTQRQSVYI....................... 169
38 -11.000PF15346.4; T1INB3_STRMM/97-247; Arginine and glutamate-rich 1  ali follow..  13  22.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KRVEEELEKRKDEIEAEVLRRVEEAKRIMEKQMLEELERRRQAELAEQTKKENEERKKREDLERIIEENNRKIEDQQRKLAEDRLAMIEEQRRLDEERHRLQREQDKQVKEEQTKILNRGKIRPKLSFSL................................... 151
39 -11.000PF15662.3; H2P8V7_PONAB/1-182; Spermatogenesis-associated protein 3 family  ali follow..  37........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PQQPSPESTPQQSSLETTSRQPASQALPAPEIRRSSRCLLSPDANVKAAPQSRKAGPLTRAGPHSCSCATCPCSSACWRRLGLCHSRIFDVLLPRDWQMAPGRGLPNFYRKPSRKPSSHRNVCPPSPRNCGCGSGGSRSCL......................... 180
40 -11.000PF04702.10; VCLB_GOSHI/29-173; Vicilin N terminal region  ali follow..  17.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RRRCEWDTRGQKEQQQCEESCKSQYGEKDQQQRHRPEDPQRRYEECQQECRQQEERQRPQCQQRCLKRFEQEQQQSQRQFQECQQHCHQQEQRPERKQQCVRECRERYQENPWRREREEEAEEEETEEG.................................... 145
41 -11.000PF02063.15; W5NK27_LEPOC/2-285; MARCKS family  ali follow..  10  142........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KKETGEGAENDGAASTDEGKDEAAATPGAADAAEEGKPAQEEAKDEAAAAVEEAKEEASPSQEAKSEEAAPEQAAAEEPKAAPAAEEPKAKEESVAEEKPAEPAAAETKAAPAAEQEAPKAEEPASATQEPAPASSPEA........................... 280
42 -11.000PF05283.9; F6ZX51_ORNAN/2-123; Multi-glycosylated core protein 24 (MGC-24), sialomucin  ali follow..  32...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SDSPSVENCTAENKTEDCSAATTTRPSPTSSSVTTQTTPNATATPVTPSPRKSSFDAASFIGGIVLVLGVQAVVFFLYKFCKS 114
43 -10.900PF16312.3; OBE2_ARATH/416-551; Coiled-coil region of Oberon  ali follow..  14  4.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RMALETCDRELEDKAKEVSELKAERQKKKLQIDELERIVRLKQAEADMFQLKANEAKREADRLQRIVLAKMDKSEEEYASNYLKQRLSEAEAEKQYLFEKIKLQENSSQSSGGGGDPSQVMMYSKIRDLL................................... 136
44 -10.900PF03064.14; U79_HHV6Z/6-234; HSV U79 / HCMV P34  ali follow..  10  100.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EGRERILTVSHENGKLQITFVTIAKVSSEPELRNLGDLKFMEKFEKECRALDRKKHDDEHRKRSGKQKEKRKVEDIDKKKEDEKRKQEEKKRNDEDKRPDKKDEFDEPPKEKRQKSHHETKRNLEEQSH.................................... 228
45 -10.800PF15772.3; G5CBI0_HETGA/104-332; UPF0688 topsan family  ali follow..  1........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LAGGVRSSARLRARSCSADIVAPVQDVAGSTSPKTACLTSSHKAPDRRTSKKFKSDKGHLVKAELQKLVSKGNSAALPEVVPRAPCKDSSAEGSALLPGSDSTAPARQEAAALPHSGCRCANDTVPAKTEDSQSPPEPCTSAAAEEADRSPRGLHEAALATGEMQMPLPQMDDDSNQPLPVSRFFGNVELMLPPASSSCPSMNRREFRKMHF.. 220
46 -10.800PF14596.4; G3HW32_CRIGR/646-844; STAT6 C-terminal  ali follow..  52....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SINVLPAFQEAPHLQMPPNMNQMSLPFDQPHPQGLLQCQSQEHAVSSPEPLLCPDVTMAEDSCLTQPVGGFPQGTWVGEVGLGNRTIHEDMFPPLLPPTEQDLTKLLLEGQGEAGGGSLGVQPLLQPSPYGQPGISMSHLDLR........................... 194
47 -10.700PF15236.4; H3A6V6_LATCH/412-563; Coiled-coil domain-containing protein 66  ali follow..  11  22.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GQSQKNSFLRTMTALLDPAEIDEREKRRQKQFEHQKAIAIQVEERRRQKQLEEERRQQEELEEELRLEQEREKIQKQFEEDVLKQKQKEELLTRKTNELYQSMQRAQEQALRLKQEHRMRELARKGHDI.................................... 150
48 -10.700PF15708.3; G7PVG9_MACFA/1-223; Proline-rich protein family 20  ali follow..  11  7.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SKRLRSMDPNQASGGRPTEPGCSIMDREASVEEPAQPAKRIAYVKPLRREPPACTELAPPAERGQRQGGSRRVGRGRGRGRGSGPRRDAGQRQGAEHLLGPDMHIQLHHHGEPGHQGEPEIRQTSAFSF........................ 140
49 -10.700PF10667.7; B4E8G7_BURCJ/1-248; Protein of unknown function (DUF2486 topsan)  ali follow..  84....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LPGDVATPAAGGETDAPAEPGAAEHVVAEEAGATMAPLRSSLVNDDLPQPTFAAMAHEAAGHAPDTAMPEAVLPSAAPQPDAQAADGLTPEDAQHIAERLRNRLTNYLTGAGREAIEARCRDALHEHSAWLVGQVT-VALALE--AVDEEIARR 245
50 -10.600PF06121.12; I3N7Y4_ICTTR/15-202; Domain of Unknown Function (DUF959 topsan)  ali follow..  22........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TDLADSRDTLVSQPQGSLPVQPAAAPATHVAPQDDPAEQRTAPASPRPPLENPKAAPSRAPGAPISAAASAAPAASPDTREENVAGVGAKIQLWNEATPTQSSAGSASAPTDPLTLAGPSGPPEESGTTLGPHRGAPGSLGT........................ 174
51 -10.600PF17040.3; D5QCK0_KOMHA/4-345; Cellulose-complementing protein A  ali follow..  10  180...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RSMNAFPRTSASSISERPVDRGVADEWSPVPKARLSPRERPRPGFFFQGMRDTRDEKKFFPVASTRSVRSNVSRMTSMTKTDTNSSQASRPGSPASPDGSPTMAEVFMTLGGRATELLSPRPSLREA-ENEEES......................... 317
52 -10.600PF15751.3; L8YCL4_TUPCH/12-113; FAAP20 FANCA interaction domain  ali follow..  12  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EREQLWADL------LRTARADLTPDGELPPLPTFPDQEPRHSPECTESPEVFTMGSKTFSWMPFPPAPRGPGDSRLLCALGEPSGSPAGPSQGQPVPDAGGTPSGEQ........................... 102
53 -10.500PF15143.4; YI023_HUMAN/33-161; Domain of unknown function (DUF4575 topsan)  ali follow..  5.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EGLALSPLLPGVPPPPAMGVPRDRGGRGAGSQSTP--RGGCLLPPRLGSQQPAGEEGLVLSPRLAGDASPCCDGSPKSQGVKRGWLSVPTSRGVPPPPAIGVLIARGGRGAGSQSLPRGWSFT.......................... 125
54 -10.400PF11018.6; Q2M131_DROPS/41-220; Pupal cuticle protein C1  ali follow..  47........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TPKTLYSAPAPVITKSIYAAAPAPVYAKTVYSAPAPVLTKTVYSAPAPVLAKTVYSAPAPVLAKTVYSAPAPVYAPAPVVTKAVYAAPAPVYAAPAPVYAKTYAAAAPTAFVKYSPAAVVSHASFDGFGSHWG................................. 179
55 -10.400PF13254.4; H6BS49_EXODN/340-786; Domain of unknown function (DUF4045 topsan)  ali follow..  17  308....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AQTKVTEPSEGPEKPAGLELKIESELPVVKPKPREEIDKPAGGDLKIESKSPIVKPKPRSTTEIDFRATLKSRQAPSTTSNDTEPEFKAVFGKLKRAQTQHYVAPDLLKDNITRGKAALNATGGPQKTQ-----------------FKESILQ. 447
56 -10.300PF02993.12; CAP6_ADE02/6-250; Minor capsid protein VI  ali follow..  11  37...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SGIKNFGSTIKNYGSKAWNSSTGQMLRDKLKEQNFQQKVVDGLASGISGVVDLANQAVQNKINSKLDPRPPVEEPPPAVETVSPEGRGEKRPRPDREETLVTQIDEPPSYEEALKQGLPTTRPIAPMATGVLGQHTPVTLDLPPPADTQQKPVLPGPSAVVVTRPSRASLRRAASGPRSMRPVASGNWQSTLNSIVGLGVQSL---------RRRCF.. 245
57 -10.100PF03535.11; H9G7Z6_ANOCA/44-248; Paxillin family  ali follow..  36........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QQPQSQSPVYSSSASGSRECVISPPRASEEEHVYSFPNKQKSAEPSPTLMSSSLGNNLSELDRLLLELNAVQHNPPSSYPADEAARTPSLPSGAGSHYSALENATSLNTQPTAPAKEKPKRNGGHGIEEVCPSV................................ 169
58 -10.100PF16601.3; H0XAD4_OTOGA/548-737; Rabosyn-5 repeating NPF sequence-motif  ali follow..  1.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SLDFREIRPFQLQAGREPRTHLAYALDLGSSPVQSSTAPKTPSPCSAQEPVQIWSGPPVLGQEFLPQSSISQQDEVPSLNPFDEEDFSSPTEEATASAPATELSSGPSAYIPKVYNPFEEEEEEEAAPFTHPDSPV......................... 136
59 -10.100PF12618.6; B7NZJ6_RABIT/176-279; Protein of unknown function (DUF3776 topsan)  ali follow..  16  3...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KDKEDKALKTEKRSRQPDQEGKLICSEKGKASERSLPENEKEDKENISENDREYSGDTQLDKKPGSDIGKSPQENLREPKRKRGRPSIAPAAVDSNSQTL....................... 103
60 -10.100PF00802.17; Q82071_HRSV/10-269; Pneumovirus attachment glycoprotein G  ali follow..  12  140............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGK--RTTTKPTKKPTLKTTKKDPKPQTTKSKEAPTTKPTEEPTINTTKTNITTTPLTSNTTRNPELTSQ--------METFHST................................ 259
61 -10.000PF02948.13; F7CBF9_CALJA/21-192; Amelogenin  ali follow..  31........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PSYGYEPMGGWLHHQIIPVLSQQHPPTHTLQPHHHIPVVPAQQPVVPQQPMMPVPGQHSMIPTQHHQPNLPPPAQQPFQPQTVQPQPHQPMQPQSPVHPMQPLPPQPPLPPMFPMQPLPPMLPDLPLEAWPATDKTKRE........................... 169
62 -10.000PF15295.4; H2UDQ9_TAKRU/4-132; Coiled-coil domain-containing protein 50 N-terminus  ali follow..  2..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EVDQTNLPRVQEVCQCFSVLEDGALAHNLQEQEIEQYYSTNIQKNQLVQNDIRVAKKLQDEEEEQWAQQSALHRQVSKQLEERDFEYARLIQEEILRCAEEAQRREQDDEEMAKRIHDEETQCRRRAS.................................... 129
63 -9.860PF08065.10; E1BPD7_BOVIN/1622-1734; K167R (NUC007) repeat  ali follow..  14  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KTPQMLCTSSQSE---LIVTPTNRKRQPRTLLGKVDTEKELSVLRRHTPASGQTMHTWCREPGVDDKSETPKQKLGPAENSAGSKRRPATPKGKAPPLEDLAGFKE........................... 108
64 -9.840PF15710.3; CS057_HUMAN/1-668; Domain of unknown function (DUF4671 topsan)  ali follow..  14  464...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QNLERDLEGFRVSPQASVVLEHREIADDPLQEPGAQQGIPDTTSELAGQRDHLPHSADQGTWADSLAVELDSQIQDALDASDFEAPPEQLFPSGNKPGPCWPGPSSHANGDPVAVAKAQPRTFVGEASRMEDATNVVRGLIVELSNLNRLIMGKRLYRK 639
65 -9.750PF07321.10; Q2SC35_HAHCH/2-150; Type III secretion protein YscO  ali follow..  2.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SALADIKKLRERNAQAEALRKRQLLTQSREKVEEAQRDLQQFEIWRVQEEHRLYDSIMGSEVGLKAIDKVKHQIGMLRLKEVSLAEQVEKARQEQKQAEAALRQAEQALAEAGKAVEKCQMLIEQVSAD.................................... 130
66 -9.710PF07960.9; CBP4_CANAL/5-137; CBP4  ali follow..  30....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PTDEQLIARFSPEVKADYERNKELRQQEQKRLIEIVKETSSSSDPIWKAGPIGSPFEKEQRNLSMELVDAELFHKTKHEEQQKQEIDRANEESKEAERLMQQ.................................... 131
67 -9.640PF16058.3; W4Y2K1_STRPU/423-517; Mucin-like  ali follow..  1..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QGDSYIQELLTPRDTYTNESFTPGHSFTNKSPAPGNSFIQELLTPRDSHTNKLLTPTDSYANESLTPGDSYIQELITPRDFYTNESLT........................ 88
68 -9.640PF08524.9; FYV7_KLULA/3-139; rRNA processing  ali follow..  14  15....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EIQRNLTKKARLKKEYLKVLKDEGYSIPEKPQYEKHDRSSVEAKKALNKQKVRDQREEHKLRKRTQKEKEQSFKEQEMKRIQLSKEKQVERDRRAKKLTQRTKRGQPVMGPKINDLLD.................................... 132
69 -9.630PF11570.6; A8ARS8_CITK8/226-361; Coiled-coil receptor-binding R-domain of colicin E2  ali follow..  14  9..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EYDKAKAELDAEDKNIATLNSRIASTEKAIPGARAAVQEADKKVKEAEANKDDFVTYNPPHEYGSGWQDQVRYLDKDIQKAAQTSLNEMNESLSRDKAALSGAMESRKQKEKKAKDAENKL................................... 135
70 -9.620PF16643.3; D5GG65_TUBMM/381-527; Unstructured region on cNMP-binding protein  ali follow..  2................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QQQLEMTARDRMDGDGENVLMRDAPATPTQSIDRLDISDLPKASSMNLTVPESRFTGPNDSNLVEPFDPDPYLPADFESLRSKSRRGSLAPPPPQSSATSSSSSPTEENPSPLSRSTTPSPVKTKH................................ 127
71 -9.620PF14179.4; D5E0H8_BACMQ/1-135; YppG-like protein  ali follow..  10  30.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HQQPWTEAYMPQHPYAQQQMPFGPQQIPYMNGMYQQPMYNNAGAPFNPYPKAQQQKPQPSQFQSLMSQFKSSDGNYDMNKMMNTAGQMMGAMNQLTSL--VKGFSGIF......... 135
72 -9.550PF05672.9; E7F930_DANRE/351-509; MAP7 (E-MAP-115) family  ali follow..  13  24.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AEKRRQARLQKEKEEEERRQKEETERKRREELARRRAEERARQEAEALKLEEEKRKREQEEQLKAAAENARIQKEEENRLQQQREEEARQSVLAEQQRVEREIRFQKEKAERQERKKRLEQIMKRTRKT.................................... 152
73 -9.470PF16789.3; D6YSB7_WADCW/3-163; YscO-like protein  ali follow..  7.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EKVMDIKKKRVDEAEKVVAAKKRELEAEREKLRKCEEERDKAVQHKIDKLNQLRDELDRGTTTDKIQQMKNYLKVVEERILVEEKKVQEQ--EQVNIAKRNLEIAQEELKMRRQEVDKLQNHKKDWIKQM................................... 135
74 -9.440PF15498.4; G3R6N2_GORGO/55-710; Nephrin and CD2AP-binding protein, Dendrin  ali follow..  13  485....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DSSLEERTFRILGLPAPEVNLRDAPTQPGSPEHQALGPAASGAQGRAEGSEVAMVQRRAGRARTPGPYAGALREAVSRIRRHTAPDSDTEAEELSVHSGSSDGSDTEAPGASWRNERTLPGVGNSSKTAELSDSVGEILDVISQ-LFGVRDIR. 648
75 -9.420PF15429.4; CA226_HUMAN/1-272; Domain of unknown function (DUF4628 topsan)  ali follow..  11  1..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MFENLNTALTPKLQASRSFPHLSKPVAPGSAPLGGEPGGPGLWVGSSQHLKNLGKAMGAKVNDFLRRKEPSSLGS--VGVTEINKTAGAQLASGTDAAPEAWLEDERSVLQETFPRLDPPPPITRKRTPRALKTTQDMLISSQP................................ 143

FFAS is supported by the NIH grant R01-GM087218-01
1 1 6 5 8 4   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Jaroszewski L, Rychlewski L, Zhang B, Godzik A. Fold prediction by a hierarchy of sequence, threading, and modeling methods. Protein Sci. 1998 Jun;7(6):1431-40.